应用较大的局部皮质类固醇量可以降低牛皮的严重程度:来自两个随机对照试验的结果
Mathias Tiedemann Svendsen1,2,3, Sören Möller1,3, Steven R Feldman1,2,4
1Department of Clinical Research, University of Southern Denmark, Odense, Denmark.
Clinical and experimental dermatology
|July 30, 2025
概括
对于牛皮,每天每1%的身体表面积 (BSA) 应用于至少1.0克局部药物是安全有效的. 延长治疗时间和更高的药物量进一步改善了牛皮的严重程度.
科学领域:
- 皮肤病学 皮肤病学
- 药理学 药理学是指药理学的学科.
- 临床试验 临床试验
背景情况:
- 局部皮质类固醇是对轻度至中度牛皮的第一线治疗.
- 对于牛皮管理的最佳局部药物剂量仍未确定.
研究的目的:
- 评估局部药物数量和治疗持续时间对牛皮治疗结果的影响.
- 为了建立局部牛皮治疗的最佳剂量指南.
主要方法:
- 两项随机对照试验的后期分析,涉及214名牛皮患者.
- 每天1%的身体表面积 (BSA) 的局部药物使用量.
- 在48周内使用格子系统医生全球评估 (LS-PGA) 评估牛皮的严重程度.
主要成果:
- 观察到平均应用量为1.0g/1%BSA/天.
- 每日局部药物使用4周改善了牛皮;延长使用至48周显示进一步显著改善 (P=0.028).
- 增加的药物量线性地降低了LS-PGA得分,每增加1g/1%的BSA/天就会使LS-PGA降低0.43分.
结论:
- 每天至少使用1.0g/1%BSA的局部药物对于牛皮是安全有效的.
- 每天应用,直到建议症状清除.
- 没有先前系统治疗史的患者表现出更大的改善.
相关概念视频
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
203
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
203
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids
397
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
397
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
176
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
176
COPD: Management Using Bronchodilators and Corticosteroids
314
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
314
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
271
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
271


